StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.02−0.09 (-8.11%)

Close on Nov 17, 2026Market cap $172.94MP/E –Yield –

Cabaletta Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cabaletta Bio's operating income for the twelve months ending Jun 30, 2026 was -$185.52M. For fiscal 2025 it was -$172.24M. The highest annual figure on record is -$6.19M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$172.24M–
FY2024Dec 31, 2024-$125.14M–
FY2023Dec 31, 2023-$74.66M–
FY2022Dec 31, 2022-$54.14M–
FY2021Dec 31, 2021-$46.31M–
FY2020Dec 31, 2020-$33.83M–
FY2019Dec 31, 2019-$18.68M–
FY2018Dec 31, 2018-$6.19M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$52.02M–
Q1 FY2026Mar 31, 2026-$44.30M–
Q4 FY2025Dec 31, 2025-$42.61M–
Q3 FY2025Sep 30, 2025-$46.59M–
Q2 FY2025Jun 30, 2025-$45.91M–
Q1 FY2025Mar 31, 2025-$37.14M–
Q4 FY2024Dec 31, 2024-$33.79M–
Q3 FY2024Sep 30, 2024-$33.05M–
Q2 FY2024Jun 30, 2024-$30.28M–
Q1 FY2024Mar 31, 2024-$28.03M–
Q4 FY2023Dec 31, 2023-$23.15M–
Q3 FY2023Sep 30, 2023-$18.67M–
Q2 FY2023Jun 30, 2023-$15.89M–
Q1 FY2023Mar 31, 2023-$16.96M–
Q4 FY2022Dec 31, 2022-$16.30M–
Q3 FY2022Sep 30, 2022-$11.78M–
Q2 FY2022Jun 30, 2022-$13.06M–
Q1 FY2022Mar 31, 2022-$13.00M–
Q4 FY2021Dec 31, 2021-$13.89M–
Q3 FY2021Sep 30, 2021-$11.56M–
Q2 FY2021Jun 30, 2021-$11.15M–
Q1 FY2021Mar 31, 2021-$9.71M–
Q4 FY2020Dec 31, 2020-$9.33M–
Q3 FY2020Sep 30, 2020-$8.42M–
Q2 FY2020Jun 30, 2020-$8.19M–
Q1 FY2020Mar 31, 2020-$7.90M–
Q4 FY2019Dec 31, 2019-$5.86M–
Q3 FY2019Sep 30, 2019-$5.03M–
Q2 FY2019Jun 30, 2019-$3.80M–
Q1 FY2019Mar 31, 2019-$3.99M–
Q4 FY2018Dec 31, 2018-$2.07M–
Q3 FY2018Sep 30, 2018-$3.08M–

More Cabaletta Bio figures

See a number that looks wrong?